BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qian W, Cai X, Qian Q, Zhang W, Wang D. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. J Cell Mol Med 2018;22:4354-65. [PMID: 29971947 DOI: 10.1111/jcmm.13725] [Cited by in Crossref: 36] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Gong F, Qu R, Li Y, Lv Y, Dai J. Astragalus Mongholicus: A review of its anti-fibrosis properties. Front Pharmacol 2022;13:976561. [DOI: 10.3389/fphar.2022.976561] [Reference Citation Analysis]
2 Wang YC, Hui JR, Xiao G, Ma QL. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation. Chin J Integr Med 2022. [PMID: 36044117 DOI: 10.1007/s11655-022-3681-x] [Reference Citation Analysis]
3 Du Q, Wu X, An L, Zhou R, Xiao X, Wu C, Wang F, Yang H. Therapeutic Effect of Astragali Radix Extract Injection Combined with Bone Marrow Mesenchymal Stem Cells in Bleomycin-Induced Pulmonary Fibrotic Rats. Evid Based Complement Alternat Med 2022;2022:4933255. [PMID: 35733628 DOI: 10.1155/2022/4933255] [Reference Citation Analysis]
4 Murthy P, Shaibie NA, Lim CL, Ling APK, Chye SM, Koh RY. An Overview of Herbal Medicines for Idiopathic Pulmonary Fibrosis. Processes 2022;10:1131. [DOI: 10.3390/pr10061131] [Reference Citation Analysis]
5 Sehgal M, Jakhete S, Manekar A, Sasikumar S. Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e09773] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Zhang Y, Xu L, Chen Q, Guan T, Lin N, Xu D, Lu L, Dai Q, Song X. Scorpion Venom Polypeptide Inhibits Pulmonary Epithelial-Mesenchymal Transition in Systemic Sclerosis-Interstitial Lung Disease Model Mice by Intervening TGF-β1/Smad Signaling Pathway. Evid Based Complement Alternat Med 2022;2022:6557486. [PMID: 35463079 DOI: 10.1155/2022/6557486] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhang B, Gao D, Xu G, Zhu W, Liu J, Sun R, Wang L, Zhang C, Ding Q, Shi Y. Integrated multicomponent analysis based on UHPLC-Q-Exactive Orbitrap-MS and network pharmacology to elucidate the potential mechanism of Baoyuan decoction against idiopathic pulmonary fibrosis. Phytochem Anal 2022. [PMID: 35396886 DOI: 10.1002/pca.3120] [Reference Citation Analysis]
8 Margaria JP, Moretta L, Alves-filho JC, Hirsch E. PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung Injury. Biomedicines 2022;10:756. [DOI: 10.3390/biomedicines10040756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Shi W, Hao J, Wu Y, Liu C, Shimizu K, Li R, Zhang C. Protective effects of heterophyllin B against bleomycin-induced pulmonary fibrosis in mice via AMPK activation. Eur J Pharmacol 2022;:174825. [PMID: 35283110 DOI: 10.1016/j.ejphar.2022.174825] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hasan M, Paul NC, Paul SK, Saikat ASM, Akter H, Mandal M, Lee SS. Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis. Molecules 2022;27:1481. [PMID: 35268581 DOI: 10.3390/molecules27051481] [Reference Citation Analysis]
11 Singh N, Arora N. Diesel exhaust exposure in mice induces pulmonary fibrosis by TGF-β/Smad3 signaling pathway. Sci Total Environ 2022;807:150623. [PMID: 34610407 DOI: 10.1016/j.scitotenv.2021.150623] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wang J, Hu K, Cai X, Yang B, He Q, Wang J, Weng Q. Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B 2022;12:18-32. [PMID: 35127370 DOI: 10.1016/j.apsb.2021.07.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
13 Adamcakova J, Mokra D. Herbal compounds in the treatment of pulmonary silicosis. Physiol Res 2021;70:S275-87. [PMID: 35099247 DOI: 10.33549/physiolres.934817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Adamcakova J, Mokra D. Herbal Compounds in the Treatment of Pulmonary Silicosis. Physiol Res. [DOI: 10.33549/10.33549/physiolres.934817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Qian H, Chen L. TRIM proteins in fibrosis. Biomed Pharmacother 2021;144:112340. [PMID: 34678729 DOI: 10.1016/j.biopha.2021.112340] [Reference Citation Analysis]
16 Qiu Y, Xing Z, Guo Z, Liu Z. Upregulation of AQP2 mediated by transcription factor FOXO1 inhibits TGF-β-induced fibrosis in human urothelial cells. Exp Ther Med 2021;22:1388. [PMID: 34650636 DOI: 10.3892/etm.2021.10824] [Reference Citation Analysis]
17 Lu J, Lin S, Lin Z, Lin X, Shen Y, Su J. PPM1A as a key target of the application of Jiawei‑Maxing‑Shigan decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells. Mol Med Rep 2021;24:825. [PMID: 34558633 DOI: 10.3892/mmr.2021.12465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Speca S, Dubuquoy C, Rousseaux C, Chavatte P, Desreumaux P, Spagnolo P. GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro. PLoS One 2021;16:e0257281. [PMID: 34529707 DOI: 10.1371/journal.pone.0257281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wu X, Huang J, Wang J, Xu Y, Yang X, Sun M, Shi J. Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects. Front Pharmacol 2021;12:707491. [PMID: 34489700 DOI: 10.3389/fphar.2021.707491] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Sui YB, Zhang KK, Ren YK, Liu L, Liu Y. The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure. Pharm Biol 2020;58:1192-8. [PMID: 33253607 DOI: 10.1080/13880209.2020.1849319] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Peng Y, Zhang Y, Zhang Y, Wang X, Xia Y. Pterostilbene alleviates pulmonary fibrosis by regulating ASIC2. Chin Med 2021;16:66. [PMID: 34321072 DOI: 10.1186/s13020-021-00474-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Liu X, Shao Y, Zhang X, Ji X, Xie M, Liu H. Calycosin attenuates pulmonary fibrosis by the epithelial-mesenchymal transition repression upon inhibiting the AKT/GSK3β/β-catenin signaling pathway. Acta Histochem 2021;123:151746. [PMID: 34217047 DOI: 10.1016/j.acthis.2021.151746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wang L, Li S, Yao Y, Yin W, Ye T. The role of natural products in the prevention and treatment of pulmonary fibrosis: a review. Food Funct 2021;12:990-1007. [PMID: 33459740 DOI: 10.1039/d0fo03001e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
24 Nwafor EO, Lu P, Liu Y, Peng H, Qin H, Zhang K, Ma Z, Xing B, Zhang Y, Li J, Liu Z. Active Components from Traditional Herbal Medicine for the Potential Therapeutics of Idiopathic Pulmonary Fibrosis: A Systemic Review. Am J Chin Med 2021;49:1093-114. [PMID: 34107859 DOI: 10.1142/S0192415X2150052X] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Cheng Z, Zhang J, Deng W, Lin S, Li D, Zhu K, Qi Q. Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis. Bioengineered 2021;12:1212-25. [PMID: 33843426 DOI: 10.1080/21655979.2021.1907128] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Zhang Y, Lu P, Qin H, Zhang Y, Sun X, Song X, Liu J, Peng H, Liu Y, Nwafor EO, Li J, Liu Z. Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential. Biomed Pharmacother 2021;133:111072. [PMID: 33378971 DOI: 10.1016/j.biopha.2020.111072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
27 Fu Y, Cai J, Xi M, He Y, Zhao Y, Zheng Y, Zhang Y, Xi J, He Y. Neuroprotection Effect of Astragaloside IV from 2-DG-Induced Endoplasmic Reticulum Stress. Oxid Med Cell Longev 2020;2020:9782062. [PMID: 33488941 DOI: 10.1155/2020/9782062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
28 Ding N, Wei B, Fu X, Wang C, Wu Y. Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis. Front Pharmacol 2020;11:591393. [PMID: 33390969 DOI: 10.3389/fphar.2020.591393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
29 Wang L, Tan Y, Gao L, Lei J, Chen C, Shi Y. Effect of astragaloside on diaphragm cell apoptosis in chronic obstructive pulmonary disease. Food Sci Nutr 2020;8:6357-66. [PMID: 33312522 DOI: 10.1002/fsn3.1751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Jin H, Jiao Y, Guo L, Ma Y, Zhao R, Li X, Shen L, Zhou Z, Kim SC, Liu J. Astragaloside IV blocks monocrotaline‑induced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling. Int J Mol Med 2021;47:595-606. [PMID: 33416126 DOI: 10.3892/ijmm.2020.4813] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Li Z, Chen H, Zhang H, Li Y, Wang C, Bai L, Zhang W, Jiang Z. Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis. ACS Omega 2020;5:30519-30. [PMID: 33283100 DOI: 10.1021/acsomega.0c04377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Peng L, Wen L, Shi QF, Gao F, Huang B, Meng J, Hu CP, Wang CM. Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation. Cell Death Dis 2020;11:978. [PMID: 33188176 DOI: 10.1038/s41419-020-03178-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
33 Chen R, Huang L, Hu K. Natural products remodel cancer-associated fibroblasts in desmoplastic tumors. Acta Pharm Sin B 2020;10:2140-55. [PMID: 33304782 DOI: 10.1016/j.apsb.2020.04.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
34 Kato M, Takahashi F, Sato T, Mitsuishi Y, Tajima K, Ihara H, Nurwidya F, Baskoro H, Murakami A, Kobayashi I, Hidayat M, Shimada N, Sasaki S, Mineki R, Fujimura T, Kumasaka T, Niwa SI, Takahashi K. Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway. Drug Des Devel Ther 2020;14:4593-603. [PMID: 33149556 DOI: 10.2147/DDDT.S264715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
35 Tang L, Zhu L, Zhang W, Yang X, Chen Q, Meng Z, Liu J, Sun Y, Hu J, Ni Z, Wang X. Qi-Xian Decoction Upregulated E-cadherin Expression in Human Lung Epithelial Cells and Ovalbumin-Challenged Mice by Inhibiting Reactive Oxygen Species-Mediated Extracellular-Signal-Regulated Kinase (ERK) Activation. Med Sci Monit 2020;26:e922003. [PMID: 32833955 DOI: 10.12659/MSM.922003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Li J, Liu J, Yue W, Xu K, Cai W, Cui F, Li Z, Wang W, He J. Andrographolide attenuates epithelial-mesenchymal transition induced by TGF-β1 in alveolar epithelial cells. J Cell Mol Med 2020;24:10501-11. [PMID: 32705806 DOI: 10.1111/jcmm.15665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhang R, Xu L, An X, Sui X, Lin S. Astragalus polysaccharides attenuate pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition and NF-κB pathway activation. Int J Mol Med 2020;46:331-9. [PMID: 32319542 DOI: 10.3892/ijmm.2020.4574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Qian W, Cai X, Qian Q, Zhang W, Tian L. Metastasis-associated protein 1 promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis by up-regulating Snail expression. J Cell Mol Med 2020;24:5998-6007. [PMID: 32187849 DOI: 10.1111/jcmm.15062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
39 Vivar R, Humeres C, Anfossi R, Bolivar S, Catalán M, Hill J, Lavandero S, Diaz-Araya G. Role of FoxO3a as a negative regulator of the cardiac myofibroblast conversion induced by TGF-β1. Biochim Biophys Acta Mol Cell Res 2020;1867:118695. [PMID: 32169420 DOI: 10.1016/j.bbamcr.2020.118695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Qian W, Cai X, Qian Q. Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition. Aging (Albany NY) 2020;12:4322-36. [PMID: 32139663 DOI: 10.18632/aging.102882] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
41 Yang B, Bai H, Sa Y, Zhu P, Liu P. Inhibiting EMT, stemness and cell cycle involved in baicalin-induced growth inhibition and apoptosis in colorectal cancer cells. J Cancer 2020;11:2303-17. [PMID: 32127957 DOI: 10.7150/jca.37242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
42 Qian W, Cai X, Qian Q, Wang D, Zhang L. Angelica Sinensis Polysaccharide Suppresses Epithelial-Mesenchymal Transition and Pulmonary Fibrosis via a DANCR/AUF-1/FOXO3 Regulatory Axis. Aging Dis 2020;11:17-30. [PMID: 32010478 DOI: 10.14336/AD.2019.0512] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
43 Li SR, Tan ZX, Chen YH, Hu B, Zhang C, Wang H, Zhao H, Xu DX. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition. Respir Res 2019;20:266. [PMID: 31775746 DOI: 10.1186/s12931-019-1232-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
44 Yang T, Chen Y, Liu J, Zhao H, Vaziri ND, Guo Y, Zhao Y. Natural products against renin-angiotensin system for antifibrosis therapy. European Journal of Medicinal Chemistry 2019;179:623-33. [DOI: 10.1016/j.ejmech.2019.06.091] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
45 Chen Z, Yao L, Liu Y, Pan Z, Peng S, Wan G, Cheng J, Wang J, Cao W. Astragaloside IV regulates NF-κB-mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF-BB-induced activation. Exp Ther Med 2019;18:3741-50. [PMID: 31641375 DOI: 10.3892/etm.2019.8047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
46 Liu Y, Lv W. Research Progress in Astragalus Membranaceus and Its Active Components on Immune Responses in Liver Fibrosis. Chin J Integr Med 2020;26:794-800. [DOI: 10.1007/s11655-019-3039-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
47 Zhu W, Zhang X, Gao K, Wang X. Effect of astragaloside IV and the role of nuclear receptor RXRα in human peritoneal mesothelial cells in high glucose‑based peritoneal dialysis fluids. Mol Med Rep 2019;20:3829-39. [PMID: 31485615 DOI: 10.3892/mmr.2019.10604] [Reference Citation Analysis]
48 Qian W, Cai X, Qian Q, Zhuang Q, Yang W, Zhang X, Zhao L. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway. Drug Des Devel Ther 2019;13:2579-89. [PMID: 31440038 DOI: 10.2147/DDDT.S207774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
49 Liu G, Zhai H, Zhang T, Li S, Li N, Chen J, Gu M, Qin Z, Liu X. New therapeutic strategies for IPF: Based on the "phagocytosis-secretion-immunization" network regulation mechanism of pulmonary macrophages. Biomed Pharmacother 2019;118:109230. [PMID: 31351434 DOI: 10.1016/j.biopha.2019.109230] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
50 Graziani V, Scognamiglio M, Esposito A, Fiorentino A, D’abrosca B. Chemical diversity and biological activities of the saponins isolated from Astragalus genus: focus on Astragaloside IV. Phytochem Rev 2019;18:1133-66. [DOI: 10.1007/s11101-019-09626-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
51 Qian W, Qian Q, Cai X, Han R, Yang W, Zhang X, Zhao H, Zhu R. Astragaloside IV inhibits oxidized low‑density lipoprotein‑induced endothelial damage via upregulation of miR‑140‑3p. Int J Mol Med 2019;44:847-56. [PMID: 31257467 DOI: 10.3892/ijmm.2019.4257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
52 Guo Z, Lou Y, Kong M, Luo Q, Liu Z, Wu J. A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine. Int J Mol Sci 2019;20:E1463. [PMID: 30909474 DOI: 10.3390/ijms20061463] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
53 Wu M, Liang G, Duan H, Yang X, Qin G, Sang N. Synergistic effects of sulfur dioxide and polycyclic aromatic hydrocarbons on pulmonary pro-fibrosis via mir-30c-1-3p/ transforming growth factor β type II receptor axis. Chemosphere 2019;219:268-76. [DOI: 10.1016/j.chemosphere.2018.12.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Tian M, Chang X, Zhang Q, Li C, Li S, Sun Y. TGF-β1 mediated MAPK signaling pathway promotes collagen formation induced by Nano NiO in A549 cells. Environ Toxicol 2019;34:719-27. [PMID: 30810263 DOI: 10.1002/tox.22738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
55 Qian W, Cai X, Qian Q, Peng W, Yu J, Zhang X, Tian L, Wang C. lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p. Cell Death Dis 2019;10:129. [PMID: 30755599 DOI: 10.1038/s41419-019-1339-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 46] [Article Influence: 11.3] [Reference Citation Analysis]
56 Qian W, Cai X, Qian Q, Zhang W, Wang D. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. J Cell Mol Med 2018;22:4354-65. [PMID: 29971947 DOI: 10.1111/jcmm.13725] [Cited by in Crossref: 36] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]